• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Influence of probiotic administration on the fecal microbiota in diarrhea-predominant irritable bowel syndrome.

作者信息

Subramanyam C, Pratap Nitesh, Gandham Prasad, Talukdar Rupjyothi, Sasikala M, Murthy H V V, Nageshwar Reddy D

机构信息

Department of Basic Sciences, Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad, 500 082, India,

出版信息

Indian J Gastroenterol. 2015 May;34(3):275-6. doi: 10.1007/s12664-015-0545-8.

DOI:10.1007/s12664-015-0545-8
PMID:25913294
Abstract
摘要

相似文献

1
Influence of probiotic administration on the fecal microbiota in diarrhea-predominant irritable bowel syndrome.益生菌给药对腹泻型肠易激综合征患者粪便微生物群的影响。
Indian J Gastroenterol. 2015 May;34(3):275-6. doi: 10.1007/s12664-015-0545-8.
2
Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.双层包衣益生菌治疗肠易激综合征的疗效：一项随机双盲对照试验。
J Gastroenterol. 2017 Apr;52(4):432-443. doi: 10.1007/s00535-016-1224-y. Epub 2016 May 13.
3
The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.双歧四联活菌片治疗腹泻型肠易激综合征的疗效：一项随机、双盲、安慰剂对照、多中心试验方案。
Trials. 2020 Jun 30;21(1):597. doi: 10.1186/s13063-020-04490-0.
4
The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.多菌种益生菌混合物对腹泻型肠易激综合征症状和粪便微生物群的影响：一项随机、双盲、安慰剂对照试验。
J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1.
5
The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.丁酸梭菌对腹泻型肠易激综合征症状和粪便微生物群的影响：一项随机、双盲、安慰剂对照试验。
Sci Rep. 2018 Feb 14;8(1):2964. doi: 10.1038/s41598-018-21241-z.
6
Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study.腹泻型肠易激综合征合并抑郁症患者对益生菌或抗抑郁药的临床特征及粪便微生物群反应：一项初步研究。
Chin Med J (Engl). 2019 Feb 5;132(3):346-351. doi: 10.1097/CM9.0000000000000071.
7
Durable alteration of the colonic microbiota by the administration of donor fecal flora.供体粪便菌群的给予可持久改变结肠菌群。
J Clin Gastroenterol. 2010 Sep;44(8):551-61. doi: 10.1097/MCG.0b013e3181e5d06b.
8
Probiotics, gut microbiota and health.益生菌、肠道微生物群与健康。
Med Mal Infect. 2014 Jan;44(1):1-8. doi: 10.1016/j.medmal.2013.10.002. Epub 2013 Nov 28.
9
Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.腹泻型肠易激综合征患者的粪便和黏膜相关肠道微生物群。
Dig Dis Sci. 2018 Jul;63(7):1890-1899. doi: 10.1007/s10620-018-5086-4. Epub 2018 May 17.
10
A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.一项关于多菌株益生菌制剂（Bio-Kult®）用于治疗腹泻型肠易激综合征的随机安慰剂对照临床试验。
BMC Gastroenterol. 2018 May 25;18(1):71. doi: 10.1186/s12876-018-0788-9.

引用本文的文献

1
The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study.多菌株益生菌对腹泻型肠易激综合征的治疗效果：一项初步研究。
Gastroenterol Res Pract. 2018 Dec 6;2018:8791916. doi: 10.1155/2018/8791916. eCollection 2018.
2
Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis.肠易激综合征中Toll样受体、促炎和抗炎细胞因子表达与肠道微生物群的关系：其微生物学基础的证据
J Neurogastroenterol Motil. 2018 Oct 1;24(4):628-642. doi: 10.5056/jnm18130.

本文引用的文献

1
A role for the gut microbiota in IBS.肠道微生物群在 IBS 中的作用。
Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):497-505. doi: 10.1038/nrgastro.2014.40. Epub 2014 Apr 22.
2
Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome.益生菌对肠易激综合征肠道微生物群的影响。
J Gastroenterol Hepatol. 2013 Oct;28(10):1624-31. doi: 10.1111/jgh.12306.
3
Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.腹泻型肠易激综合征患者肠道微生物群落组成和多样性的改变。
Neurogastroenterol Motil. 2012 Jun;24(6):521-30, e248. doi: 10.1111/j.1365-2982.2012.01891.x. Epub 2012 Feb 20.
4
Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome.肠道微生物组和有机酸的改变可能是肠易激综合征症状的根源。
Neurogastroenterol Motil. 2010 May;22(5):512-9, e114-5. doi: 10.1111/j.1365-2982.2009.01427.x. Epub 2009 Nov 10.